Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention.
Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
ß-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
ß-Blocker use for patients with or at risk for coronary artery disease--reply.
Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes.
Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator.
Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction.
Lack of negative interaction between use of ß-blockers and statins on cardiovascular outcomes among patients with or at risk for atherothrombosis.
ß-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.
Myocardial bridging in a man with non-ST-elevation myocardial infarction.
Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.
Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
Heart failure medications prescribed at discharge for patients with left ventricular assist devices.
Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
Adrenergic beta Antagonists